258 related articles for article (PubMed ID: 17076189)
1. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of DNA content in epithelial ovarian cancer.
Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic significance of DNA ploidy pattern on bile duct cancer].
Sato Y; Tanaka J; Seki H; Kato Y; Umezawa A; Koyama K
Nihon Geka Gakkai Zasshi; 1994 Apr; 95(4):259-62. PubMed ID: 8196593
[TBL] [Abstract][Full Text] [Related]
6. Ploidy as a prognostic factor in ovarian cancer.
Friedlander ML; Taylor IW; Russell P; Musgrove EA; Hedley DH; Tattersall MH
Int J Gynecol Pathol; 1983; 2(1):55-63. PubMed ID: 6307906
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between DNA ploidy and survival in breast cancer].
Utada Y; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():431-5. PubMed ID: 9589048
[TBL] [Abstract][Full Text] [Related]
8. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
Friedlander ML; Hedley DW; Swanson C; Russell P
J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma.
Kaern J; Tropé CG; Kristensen GB; Pettersen EO
Cancer; 1994 Apr; 73(7):1870-7. PubMed ID: 8137213
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic significance of Sphase fraction in ovarian cancer patients].
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
Ginekol Pol; 2006 Nov; 77(11):840-7. PubMed ID: 17378122
[TBL] [Abstract][Full Text] [Related]
11. Effect of cellular DNA content on the prognosis of epithelial ovarian cancers.
Ozalp S; Yalcin OT; Gulbas Z; Tanir HM; Minsin T
Gynecol Obstet Invest; 2001; 52(2):93-7. PubMed ID: 11586035
[TBL] [Abstract][Full Text] [Related]
12. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy analysis of borderline epithelial ovarian tumours.
Lodhi S; Najam S; Pervez S
J Pak Med Assoc; 2000 Oct; 50(10):349-51. PubMed ID: 11109755
[TBL] [Abstract][Full Text] [Related]
15. Ploidy analysis of epithelial ovarian cancers using image cytometry.
Berchuck A; Boente MP; Kerns BJ; Kinney RB; Soper JT; Clarke-Pearson DL; Bast RC; Bacus SS
Gynecol Oncol; 1992 Jan; 44(1):61-5. PubMed ID: 1370427
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
Lage JM; Weinberg DS; Huettner PC; Mark SD
Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
[TBL] [Abstract][Full Text] [Related]
17. Ovarian carcinoma heterogeneity as demonstrated by DNA ploidy.
Zangwill BC; Balsara G; Dunton C; Varello M; Rebane BA; Hernandez E; Atkinson BF
Cancer; 1993 Apr; 71(7):2261-7. PubMed ID: 8453547
[TBL] [Abstract][Full Text] [Related]
18. DNA ploidy and survival in breast cancer patients.
Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of nuclear DNA content in patients with recurrent epithelial ovarian cancer.
Hamaguchi K; Nishimura H; Tateno N; Yakushiji M; Yokoyama MM
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2836-42. PubMed ID: 2074393
[TBL] [Abstract][Full Text] [Related]
20. [Flow cytometric analysis of DNA ploidy pattern in advanced gastric cancer and its relationship with prognosis].
Kimura H; Yonemura Y; Iwasa K; Ohyama S; Kosaka T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):288-92. PubMed ID: 2051980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
